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Abstract
Background: Matricaria chamomilla and Melissa officinalis have been used as antidepressants in traditional Iranian medicine.
Objectives: The aim of this study was to determine the effectiveness of Matricaria chamomilla and Melissa officinalis extracts com-
pared to the classic antidepressant drug, imipramine, in adult non-reserpinized and reserpinized mice through the forced swim
test.
Methods: In the current experimental study, 80 mice were divided into 10 groups. The first group received normal saline and the
second and third groups received 25 and 50 mg/kg of Matricaria chamomilla extract, respectively. The fourth and the fifth groups
received 25 and 50 mg/kg of Melissa officinalis extract. The sixth group received imipramine at a dose of 15 mg/kg. The seventh
group received 5 mg/kg of reserpine and normal saline. The eighth and ninth groups received 25 and 50 mg/kg of Melissa officinalis
and Matricaria chamomilla extracts, respectively. The tenth group was given imipramine through intraperitoneal (I.P) injection.
Statistical analyses were performed using one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test in SPSS.
Results: Matricaria chamomilla (50 mg/kg), Melissa officinalis (25 mg/kg), and imipramine (15 mg/kg) in non-reserpinized mice signif-
icantly decreased the duration of immobility in the forced swim test compared to the control group (P < 0.01). There was a reduction
in the duration of immobility in the reserpinized mice administered Matricaria chamomilla at a dose of 50 mg/kg compared to the
positive control group (P < 0.01).
Conclusions: Matricaria chamomilla and Melissa officinalis have antidepressant effects and may be taken into consideration in treat-
ing patients suffering from depression.
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1. Background
Depression is an increasingly common aﬄiction that
has received growing consideration from the World Health
Organization (WHO) (1). From a clinical perspective, it is
accompanied by a variety of other disorders such as sex-
ual disabilities, pregnancy complications (2), mental dis-
orders, loss of appetite, and sleep irregularities (3). It af-
fects 25% of women and 12% of men (4-6). According to the
WHO, approximately 12.3% of the population are currently
suffering from mental and behavioral disorders, and this
number is expected to rise to 15% by 2020. However, only
a small proportion of those with depression are receiv-
ing proper treatment (7). Depression is the second lead-
ing cause of disability after cardiovascular diseases in in-
dustrialized countries (6, 8). Statistically, the proportion
of people diagnosed with depression in Iran is approxi-
mately 4.1% (1), which is twice as much as China (2%) (8) and
Japan (2.9%) (9), but less than the reports from the US (6.6%)
(10) and Ukraine (8.3%) (11). Dramatic social and economic
changes have impacted Iranians in recent decades (1) and
have resulted in a spike in the consumption of synthetic
medications and their subsequent side effects (12). Under-
standing preventive methods and using herbal treatments
can help with the prevention of the undesirable side effects
of synthetic drugs (13).
It is believed that the majority of the available an-
tidepressant drugs are associated with increased exposure
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to synaptic monoamines such as serotonin (5-ht), nore-
pinephrine (NE), and dopamine (DA) (14, 15). It is worth
mentioning that one-third of patients with severe depres-
sion do not respond to treatment (4). There are currently
three different methods for measuring the effectiveness of
antidepressants, namely the Hamilton survey among hu-
mans (6, 16) and the forced swim test (3) and tail suspen-
sion test among mice (6, 14).
According to the monoamine hypothesis among lab
animals, reserpine can block dopamine receptors (17)
and subsequently cause dopamine depletion by empty-
ing monoamine resources (14, 17). This can lead to severe
depression followed by a drop in body temperature and
a lack of movement (14). Throughout the past decade,
widespread studies have been conducted on the antide-
pressant effects of herbal medications on lab animals (18,
19). The current study sought to investigate the effects of
herbal antidepressants with fewer side effects.
Melissa officinalis (lemon balm) is an herb of the Lami-
aceae family. This plant is known as Badranj Boya in Iran.
It has been used for more than 2000 years and is found
along the Mediterranean and in Europe and Central Asia.
In Iran, it is found in several provinces such as Tehran,
Golestan, Azerbaijan, Lorestan, and Kermanshah (20). In
Iranian traditional medicine, this plant is commonly used
as an antidepressant (19), a sedative, and an agent decreas-
ing stress, relieving anxiety, increasing levels of body an-
tioxidants, and treating inflammation and spasms (21).
This plant contains several monoterpene aldehydes and
flavonoids (e.g., quercitrin and rhamnocitrin) (22). Pheno-
lic compounds found in lemon balm include rosmarinic
acid, tannins, and flavonoids (23-25). Recent studies have
shown that Melissa officinalis extract contains rosmarinic
acid, triterpenoids, oleanolic acid, and ursolic acid, which
inhibit gamma-aminobutyric acid transaminase (GABA-T)
activity (26) and increase GABA levels in the brain, which
can cause dysfunction in the GABA-T and lead to an abun-
dance of GABA-T in brain cells (27).
Matricaria chamomile belongs to the Asteraceae fam-
ily and is one of the herbal medications most com-
monly used in Iranian traditional medicine. Matricaria
chamomile is found in Asia, the Mediterranean, North
Africa, North and South America, Australia, and New
Zealand (28). Its dried flowers have sedative properties
(29) and are effective in treating spasms, nephritis, men-
strual cramps, nausea, acne, and mouth ulcers. It also
works as a disinfectant (28) as a component of the flow-
ers includes several phenolic compounds, primarily the
flavonoids apigenin, quercetin, patuletin, luteolin, gluco-
sides coumarins, and dicycloethers (30).
Flavonoids are regarded as natural polyphenolic com-
pounds and are commonly found in nature. Studies have
shown that flavonoids have some biological functions,
and with their antioxidant effects, they can help reduce
the risks of human immunodeficiency virus (HIV), bacte-
rial infections, cancer, and diabetes, ameliorate the effects
of radiation, reduce blood vessel expansion, and prevent
atherosclerosis and thrombosis (31, 32).
2. Objectives
Many natural alternatives to antidepressant medica-
tions are considered safer in the treatment of depression.
Flavonoids have been the focus of recent antidepressant
studies as they have been shown to have antidepressant ef-
fects. The aim of the current study was to determine the
antidepressant-like effects of Matricaria chamomilla and
Melissa officinalis ethanolic extracts on reserpinized mice
through the forced swim test.
3. Methods
3.1. Plant Extract Preparation
First, the plant samples of both Matricaria chamomilla
and Melissa officinalis were purchased from a local provider
in Shahrekord, and their authenticity was verified in the
Medical Plants Research Center, Shahrekord Branch, Is-
lamic Azad University. They were then labeled as 406 and
407. During the preparation phase of the ethanolic ex-
tracts, air-dried and powdered flowering branches of the
plants were macerated with 70% ethanol (96%, Ghadir In-
dustries, Iran) for 48 h. The macerated powder was then
shaken, filtered, and evaporated in a rotary evaporator un-
der reduced pressure until dry (20, 33).
3.2. Animals
In the current experimental study, 80 albino Balb/C fe-
male mice (weight: 20 - 25 g) were acquired from Pasteur
Institute of Iran. After being sent to the Islamic Azad Uni-
versity of Shahrekord, the mice were kept in poly-carbon
cages at 21°C - 25°C in 12 hours of light and 12 hours of dark-
ness. Eight mice were placed in each cage with free access
to water and a commercial pellet diet (20, 23). This study
was performed in accordance with the guide for the care
and use of laboratory animals of the Islamic Azad Univer-
sity of Shahrekord, Iran.
3.3. Choice of Drugs
Imipramine hydrochloride (Pars Daru, Tehran, Iran) at
a dose of 15 mg/kg was injected intraperitoneally (I.P) (19).
Matricaria chamomilla and Melissa officinalis extracts were
freshly prepared before I.P administration at the doses of
25 and 50 mg/kg, respectively. Imipramine hydrochloride
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(15 mg/kg, I.P) was injected 30 minutes before the forced
swim test, and immobility time records were documented.
Then, in order to induce depression, reserpine (Sigma-
Aldrich, MO, USA) was mixed with normal saline (0.9%) and
0.8% acid glacial acetic acid (34) and injected at a dose of 5
mg/kg 18 hours before the forced swim test (35) in order to
clear aminergic receptors from amine.
3.4. Arrangement of the Experimental Groups
In order to analyze the antidepressant effects of the hy-
droalcoholic extracts of Matricaria chamomilla and Melissa
officinalis in nonreserpinized and reserpinized mice, they
were divided into 10 groups of 8 (Table 1).
3.5. Forced Swim Test
The forced swim test was performed according to pre-
vious protocols (36). First, water containers (height 25 cm
and diameter 12 cm) were chosen and filled with 25°C wa-
ter. Then, the mice were gently put in the container from
a height of 20 cm, and as commonly accepted, the lack of
hand movement was considered as motionless state. The
test time was set to 6 minutes, with the first 2 minutes des-
ignated for acclimatization to the new environment and
not taken into account. After two minutes, the movements
were recorded, documented, and timed (37). The contain-
ers were thoroughly cleaned to reduce residue, urine, and
soft hair. Each animal was used only once. Immediately af-
ter the test, the mice were dried in a room with a tempera-
ture of 29°C - 31°C (12).
3.6. Statistical Analysis
All the data are presented as mean± SEM. Differences
between the experimental groups were evaluated by one-
way analysis of variance (ANOVA) followed by Tukey’s post
hoc test. P value less than 0.01 was considered significant.
4. Results
4.1. Findings Regarding the Common Antidepressant Ef-
fects of the Hydroalcoholic Extracts of Melissa officinalis and
Matricaria chamomilla and Imipramine Among Adult Non-
Reserpinized Mice
According to our data, injection of the hydroalco-
holic extracts of Matricaria chamomilla (50 mg/kg, I.P) and
Melissa officinalis (25 mg/kg) and imipramine (15 mg/kg)
significantly reduced immobility time during the forced
swim test (P < 0.01; Table 2). However, the hydroalcoholic
extracts of Matricaria chamomilla and Melissa officinalis at
the at the doses of 25 and 50 mg/kg respectively had no ef-
fects on immobility time compared to the saline group (P
> 0.05; Table 2).
4.2. The Effects of the Hydroalcoholic Extracts of Matricaria
chamomilla and Melissa officinalis and Imipramine on Immo-
bility Duration of the Reserpinized Mice
The most active compound in the forced swim test was
Matricaria chamomile (50 mg/kg), which significantly an-
tagonized the reserpine action and decreased the immo-
bility time (P < 0.01), whereas the I.P injection of the hy-
droalcoholic extract of Melissa officinalis (25 mg/kg) and
imipramine (15 mg/kg) 18 hours after the injection of reser-
pine (5 mg/kg) had no effects on reserpine-induced immo-
bility time and did not antagonize reserpine (P > 0.1; Table
3).
5. Discussion
In the present study, we used the forced swim test to
compare the effects of the hydroalcoholic extracts of Ma-
tricaria chamomilla and Melissa officinalis and imipramine
(standard antidepressant) on behaviors, including immo-
bility, in reserpinized and non-reserpinized mice. The
forced swim test, as described in detail by Abelaira et al.
(37), was used to evaluate depressive behavior.
As previously mentioned, many neurotransmitters are
involved in the pathophysiology of depression. Accord-
ing to the monoamine hypothesis, the increase of neu-
rochemicals during depression might be a result of sero-
tonin, norepinephrine, and/or dopamine depletion in the
central nervous system (38). Antidepressant drugs can
immediately increase synaptic concentrations of these
monoamines (39) and are able to reduce the immobility
time in rodents (3).
Reserpine-induced depression in animal models is
based on the monoamine hypothesis of depression with
reductions of brain levels of both serotonin and nora-
drenaline and declined locomotion (14, 17). In the cur-
rent study, the antidepressant effects of Melissa officinalis
and Matricaria chamomilla extracts at the doses of 25 and
50 mg/kg, respectively, were evaluated through the forced
swim test. There was a significant decrease in the immo-
bility time following the intraperitoneal injection of Ma-
tricaria chamomilla at the dose of 50 mg/kg and Melissa
officinalis at the of 25 mg/kg compared to the control
group. As for Matricaria chamomilla extract, there was a di-
rect correlation between dosage and immobilization time,
and regarding reserpine, there was a significant correla-
tion between the antagonizing effects of reserpine and
Melissa officinalis and Matricaria chamomilla extracts (P <
0.001). Also, following the intraperitoneal injection of
imipramine, there was a significant attenuation in immo-
bilization time among the mice in the forced swim test,
which was eventually antagonized by reserpine.
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Table 1. Treatments for Forced Swim Test in Mice
Group (N = 8) Treatment (I.P)
FST1 (negative control) Normal saline 10 mL kg-1
FST2 Matricaria chamomilla extract 50 mg kg-1
FST3 Matricaria chamomilla extract 25 mg kg-1
FST4 Melissa officinalis extract 25 mg kg-1
FST5 Melissa officinalis extract 50 mg kg-1
FST6 (positive control) Imipramine hydrochloride 15 mg kg-1
FST7 (negative control) Reserpine 5 mg kg-1 , normal saline 10 mL kg-1
FST8 Reserpine 5 mg kg-1 , Melissa officinalis extract 25 mg kg-1
FST9 Reserpine 5 mg kg-1 , Matricaria chamomilla extract 50 mg kg-1
FST10 (positive control) Reserpine 5 mg kg-1 , imipramine hydrochloride 15 mg kg-1
Table 2. Effects of the Hydroalcoholic Extracts of Melissa officinalis and Matricaria chamomilla and Imipramine on Immobility Duration in Adult Non-Reserpinized Micea
Treatments Immobility Times (s) P Value
Normal saline 10 mL kg-1 184.83± 5.65 -
Matricaria chamomilla extract 25 mg kg-1 175± 7.30 0.98
Matricaria chamomilla extract 50 mg kg-1 62.17± 7.91 0.00
Melissa officinalis extract 25 mg kg-1 128± 8.67 0.00
Melissa officinalis extract 50 mg kg-1 150.83± 4.84 0.055
Imipramine hydrochloride 15 mg kg-1 68± 7.78 0.00
a Values are expressed as mean± SEM. One-way ANOVA, post hoc Tukey test, (N = 8).
Table 3. Effects of the Hydroalcoholic Extracts of Matricaria chamomilla and Melissa officinalis on Immobility Duration in Adult Reserpinized Mice Compared to Imipraminea
Treatments Immobility Times (s) P Value
Reserpine 5 mg kg-1 , normal saline 10 mL kg-1 208.60± 6.313 0.368
Reserpine 5 mg kg-1 , Melissa officinalis extract 25 mg kg-1 211± 1.71 0.190
Reserpine 5 mg kg-1 , Matricaria chamomilla extract 50 mg kg-1 142± 14.795 0.003
Reserpine 5 mg kg-1 , imipramine hydrochloride 15 mg kg-1 182.67± 3.211 1.00
a Values are expressed as mean± SEM. One-way ANOVA, post hoc Tukey test, (N = 8).
In a study by Moallem et al. in 2007, it was con-
cluded that antidepressants could selectively prevent the
reabsorption of serotonin and norepinephrine, which
in turn, can lead to a decrease in immobilization du-
ration and a surge in ascending activities (40). The
mechanism of antidepressant effects of the Matricaria
chamomilla and Melissa officinalis ethanolic extracts is un-
known, but it seems that flavonoids such as apigenin,
naringenin, quercetin, chrysin, catechinic acid, epicate-
chin, kaempferol, and fisetin can have a preventive effect
against monoamine oxidases. The strongest inhibitors
of the combination of ligand and benzodiazepine recep-
tors can be used as antidepressants (41, 42). Furthermore,
flavones can bind to GABA-A, which can have soothing and
relaxing effects (43). Yi et al. pointed out that dietary
flavonoids have multiple neuroprotective actions in cen-
tral nervous pathophysiological conditions, including de-
pression, and it was reported that naringenin can cause a
potent antidepressant-like impact via central serotonergic
and noradrenergic systems (44).
This study also showed that an increase in the dosage
of Matricaria chamomilla extract from 25 to 50 mg/kg de-
creased the immobilization duration in the forced swim
test. In addition, the flavones available in leaves and flow-
ers can have a suppressing effect on monoamine oxidase,
which in turn, can cause antidepressant effects (40, 43).
It is commonly believed that improving brain monoamin-
ergic functions is beneficial in treating depression, and
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the serotonergic, noradrenergic, or dopaminergic systems
have become targets for the development of antidepres-
sants (45).
Reserpine-treated rats exhibited decreased levels of su-
peroxide dismutase, catalase, and glutathione peroxidase
in the cranial lobe of the brain (46), which could sub-
sequently trigger oxidative stress and pseudo-depression
syndrome in animals (12). Thus, blocked monoamine ox-
idase can prevent catecholamines from getting metabo-
lized, which can minimize the effects of depression (47).
The majority of available medications such as amitripty-
line, imipramine, and clomipramine can help reduce de-
pression and cause selective inhibition and reabsorption
of both norepinephrine and serotonin (48). Previous stud-
ies reported that the intraperitoneal administration of
imipramine (10, 20, and 30 mg/kg) reduced lipid and
protein peroxidation and increased superoxide and cata-
lase activities, compared to control groups, in the hip-
pocampus and prefrontal cortex (49). Some herbal med-
ications such Melissa officinalis and Matricaria chamomilla
contain flavonoids such as quercetin, apigenin, and lu-
teolin, which can potentially have antidepressant effects
(31) and can probably inhibit monoamine oxidase. How-
ever, further experiments are needed to confirm the ac-
tive anti-depressant effects of Melissa officinalis and Matri-
caria chamomilla and their corresponding mechanisms of
action.
5.1. Conclusions
This study confirmed that the hydroalcoholic extract
of Matricaria chamomilla at the dose of 50 mg/kg was far
more effective than imipramine and the hydroalcoholic ex-
tract of Melissa officinalis in reducing immobilization time.
Thus, the administration of Matricaria chamomilla may be
beneficial in the management of depression.
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